These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9097693)

  • 1. [Assessment of myocardial energy metabolism with PET].
    Kinoshita S; Serizawa T
    Nihon Rinsho; 1997 Mar; 55 Suppl 1():644-7. PubMed ID: 9097693
    [No Abstract]   [Full Text] [Related]  

  • 2. [Imaging of myocardial perfusion and metabolism with positron emission tomography].
    Ishida Y; Fukuchi K; Oka M; Sagoh M; Miyake Y; Hasimoto N
    Nihon Rinsho; 1998 Mar; 56(3):813-23. PubMed ID: 9549377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Positron emission tomography: the prospects for studying myocardial metabolism in vivo].
    Ashmarin IIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):103-7. PubMed ID: 6391515
    [No Abstract]   [Full Text] [Related]  

  • 4. Positron-emission tomography: assessment of myocardial blood flow and metabolism.
    Schelbert HR
    Circulation; 1985 Nov; 72(5 Pt 2):IV122-33. PubMed ID: 3902283
    [No Abstract]   [Full Text] [Related]  

  • 5. [Assessment of myocardial circulation and metabolism using positron CT].
    Shishido F; Uemura K; Kanno I; Murakami M; Ono Y; Takahashi A
    J Cardiol Suppl; 1987; 15():61-3. PubMed ID: 3509906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simplified PET quantitation of myocardial glucose utilization.
    Nakagawa K; Namba H; Iyo M; Fukushi K; Irie T; Yamanouchi M; Shikama N; Himi T; Yoshida K; Masuda Y
    J Nucl Med; 1995 Nov; 36(11):2094-102. PubMed ID: 7472605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron tomography and myocardial metabolism: an overview.
    Sobel BE
    Circulation; 1985 Nov; 72(5 Pt 2):IV22-30. PubMed ID: 3931935
    [No Abstract]   [Full Text] [Related]  

  • 8. Limitations of myocardial FDG studies.
    McFalls EO
    Circulation; 1995 Nov; 92(10):3145. PubMed ID: 7586289
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
    Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
    J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and economic controversies in radionuclide assessment of myocardial viability.
    Alagona P
    Circulation; 1995 Nov; 92(10):3145-6. PubMed ID: 7586290
    [No Abstract]   [Full Text] [Related]  

  • 12. [Assessment of regional myocardial blood flow and energy metabolism].
    Yonekura Y; Senda M; Torizuka K
    J Cardiol Suppl; 1987; 15():65-9. PubMed ID: 3509973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarction.
    Rubin PJ; Lee DS; Dávila-Román VG; Geltman EM; Schechtman KB; Bergmann SR; Gropler RJ
    Am J Cardiol; 1996 Dec; 78(11):1230-5. PubMed ID: 8960580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical approaches to metabolism: application to positron-emission tomography.
    McMillin-Wood JB
    Circulation; 1985 Nov; 72(5 Pt 2):IV145-50. PubMed ID: 2865017
    [No Abstract]   [Full Text] [Related]  

  • 15. [PET and cardiovascular research].
    Harumi K; Hara T; Iio T; Okazaki O
    Kokyu To Junkan; 1992 Feb; 40(2):113-20. PubMed ID: 1565876
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of myocardial glucose utilization of hypertrophic and dilated cardiomyopathy using 18F-2-fluoro 2-deoxy-D-glucose and positron emission tomography].
    Ohtake T; Kosaka N; Watanabe T; Momose T; Nishikawa J; Sasaki Y; Iio M; Yokoyama I; Iizuka M; Sugimoto T
    Nihon Rinsho; 1991 Jan; 49(1):143-7. PubMed ID: 2002593
    [No Abstract]   [Full Text] [Related]  

  • 17. Myocardial metabolic changes in hypertrophic cardiomyopathy.
    Tadamura E; Tamaki N; Matsumori A; Magata Y; Yonekura Y; Nohara R; Sasayama S; Yoshibayashi M; Kamiya T; Konishi J
    J Nucl Med; 1996 Apr; 37(4):572-7. PubMed ID: 8691242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography.
    Hicks RJ; Herman WH; Kalff V; Molina E; Wolfe ER; Hutchins G; Schwaiger M
    J Am Coll Cardiol; 1991 Jul; 18(1):101-11. PubMed ID: 2050912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PET assessment of myocardial viability with glucose loading and fasting FDG images].
    Niwayama H; Yoshida K; Kagaya A; Himi T; Masuda Y; Inagaki Y; Ito Y; Uematsu S; Imazeki K; Arimizu N
    Kaku Igaku; 1990 Mar; 27(3):285-8. PubMed ID: 2352373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and limitations of metabolic tracers labeled with positron-emitting radionuclides in the identification of viable myocardium.
    Bergmann SR
    J Nucl Med; 1994 Apr; 35(4 Suppl):15S-22S. PubMed ID: 8151408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.